共 9 条
[1]
[2]
Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease <ce:link locator="fx1"/>.[J].Paul Rutgeerts;Robert H. Diamond;Mohan Bala;Allan Olson;Gary R. Lichtenstein;Weihang Bao;Kamlesh Patel;Douglas C. Wolf;Michael Safdi;Jean Frederic Colombel;Bret Lashner;Stephen B. Hanauer.Gastrointestinal Endoscopy.2006, 3
[3]
American Gastroenterological Association Institute Medical Position Statement on Corticosteroids; Immunomodulators; and Infliximab in Inflammatory Bowel Disease.[J].Gary R. Lichtenstein.Gastroenterology.2006, 3
[5]
Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: the CLASSIC-I Trial.[J].Stephen B. Hanauer;William J. Sandborn;Paul Rutgeerts;Richard N. Fedorak;Milan Lukas;Donald MacIntosh;Remo Panaccione;Douglas Wolf;Paul Pollack.Gastroenterology.2006, 2
[7]
[9]
Cortisone In Ulcerative Colitis. Final Report On A Therapeutic Trial.[J].S. C. Truelove;L. J. Witts;R. E. Tunbridge;G. Watkinson;F. Avery Jones;Richard Doll;T. L. Hardy;C. R. St. Johnston;W. I. Card;Maxwell Wilson;John Taylor.The British Medical Journal.1955, 4947

